Recently, most of the cancer-related mRNA targets of IGF2BP1 have been shown to promote tumor proliferation.[22] Huang et al[23] demonstrated that IGF2BP could bind to the m6A sites of the MYC gene and loss of IGF2BP inhibited the proliferation and migration of hepatocellular carcinoma and CC. The gene discussed is MYC; the disease is cancer.